COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 165: Articles 1641-1650  | Next

SARS-CoV-2 variants from long-term, persistently infected immunocompromised patients have altered syncytia formation, temperature-dependent replication, and serum neutralizing antibody escape
Wouters, C., Sachithanandham, J., Akin, E., Pieterse, L., Fall, A., Truong, T. T., Bard, J. D., Yee, R., Sullivan, D. J., Mostafa, H. H., Pekosz, A.
10.1101/2024.05.18.594818 — Posted: 2024-05-20
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis
Zhu, J., Liu, G., Goins, C. M., Stauffer, S. R., Gack, M. U.
10.1101/2024.05.15.594393 — Posted: 2024-05-20
Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID
Schuermans, A., Verstraete, A., Lammi, V., Nakanishi, T., Ardissino, M., Van den Eynde, J., Sun, B., Georgakis, M. K., Van Weyenbergh, J., Lewandowski, A. J., Raman, B., Ollila, H. M., Burgess, S., Natarajan, P., Honigberg, M. C., Freson, K., Vanassche, T., Verhamme, P.
10.1101/2024.05.17.24307553 — Posted: 2024-05-18
Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Dragotakes, Q., Sullivan, D. J., Carter, R., Joyner, M. J., Bloch, E. M., Gebo, K. A., Hanley, D. F., Henderson, J. P., Pirofski, L.-a., Shoham, S., Senefeld, J., Tobian, A. A., Wiggins, C. C., Wright, R. S., Paneth, N. S., Casadevall, A.
10.1101/2024.05.16.24307505 — Posted: 2024-05-18
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Rothman, R. L., Stewart, T. G., Mourad, A., Boulware, D., McCarthy, M. W., Thicklin, F., Garcia del Sol, I. T., Garcia, J. L., Bramante, C., Shah, N. S., Singh, U., Williamson, J. C., Rebolledo, P. A., Jagannathan, P. C., Schwasinger-Schmidt, T., Ginde, A. A., Castro, M., Jayaweera, D., Sulkowski, M., Gentile, N., McTigue, K., Felker, G. M., DeLong, A., Wilder, R., Collins, S., Dunsmore, S. E., Adam, S. J., Hanna, G. J., Shenkman, E., Hernandez, A. F., Naggie, S., Lindsell, C. J.
10.1101/2024.05.16.24307115 — Posted: 2024-05-18
Impact of Covid-19 on Bangladeshi university students mental health: ML and DL analysis
Atique, M. M. A. B., Bappi, M. I., Kim, K., Choi, K., Ahamad, M. M., Reza, K. M.
10.1101/2024.05.17.24307476 — Posted: 2024-05-17
Individual Patient Data Meta-Analysis evaluating Camostat Mesilate to Treat COVID-19 in Community Settings
Hedlin, H., Tobback, E., Lee, J., Wang, Y., Dragoni, I., Anthony, D. C., Dhaliwal, K., Norrie, J., Halford, S., Gotes, J., Moctezuma, M., Olivas-Martinez, A., Khosla, C., Singh, U., Damsgaard Gunst, J., Valdez, A., Kershenobich, D., Boutboul, D., Sogaard, O. S., De Scheerder, M.-A., Desai, M., Parsonnet, J., Camostat Pooled Analysis Consortium
10.1101/2024.05.15.24307072 — Posted: 2024-05-17
Interleukin-1 prevents SARS-CoV-2-induced membrane fusion to restrict viral transmission via induction of actin bundles
Zheng, X., Yu, S., Zhou, Y., Yu, K., Gao, Y., Chen, M., Duan, D., Li, Y., Cui, X., Mou, J., Yang, Y., Wang, X., Chen, M., Jiu, Y., Zhao, J., Meng, G.
10.1101/2024.05.16.594569 — Posted: 2024-05-17
Spike protein of the SARS-CoV-2 omicron variant interacts with actin
Fujimoto, A., Kawai, H., Kawamura, R., Kitamura, A.
10.1101/2024.05.16.594608 — Posted: 2024-05-17
Physician burnout in the context of the COVID-19 pandemic: prevalence and associated factors among resident doctors and consultants in Delta State, Nigeria
Moeteke, N. S., Erhirhie, E.
10.1101/2024.05.15.24307433 — Posted: 2024-05-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).